Cargando…

Genome-Wide and Locus Specific Alterations in CDC73/HRPT2-Mutated Parathyroid Tumors

Mutations in the hyperparathyroidism type 2 (HRPT2/CDC73) gene and alterations in the parafibromin protein have been established in the majority of parathyroid carcinomas and in subsets of parathyroid adenomas. While it is known that CDC73-mutated parathyroid tumors display specific gene expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sulaiman, Luqman, Haglund, Felix, Hashemi, Jamileh, Obara, Takao, Nordenström, Jörgen, Larsson, Catharina, Juhlin, C. Christofer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460869/ https://www.ncbi.nlm.nih.gov/pubmed/23029479 http://dx.doi.org/10.1371/journal.pone.0046325

Ejemplares similares

Genetic characterization of large parathyroid adenomas
por: Sulaiman, Luqman, et al.
Publicado: (2012)

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

Novel HRPT2/CDC73 Gene Mutations and Loss of Expression of Parafibromin in Chinese Patients with Clinically Sporadic Parathyroid Carcinomas
por: Wang, Ou, et al.
Publicado: (2012)

Inflammatory infiltrates in parathyroid tumors
por: Haglund, Felix, et al.
Publicado: (2017)

Diffuse PTH expression in parathyroid tumors argues against important functional tumor subclones
por: Haglund, Felix, et al.
Publicado: (2016)

Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weight
por: Haglund, Felix, et al.
Publicado: (2015)

Recurrence of Hyperparathyroid Hypercalcemia in a Patient With the HRPT-2 Mutation and a Previous Parathyroid Carcinoma in Hyperparathyroidism-Jaw Tumor Syndrome
por: Mele, Marco, et al.
Publicado: (2016)

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer
por: Cetani, Filomena, et al.
Publicado: (2013)

Human-relevant potency threshold (HRPT) for ERα agonism
por: Borgert, Christopher J., et al.
Publicado: (2018)

Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion
por: Muscarella, Lucia Anna, et al.
Publicado: (2018)

CDC73 Intragenic Deletion in Familial Primary Hyperparathyroidism Associated With Parathyroid Carcinoma
por: Korpi-Hyövälti, Eeva, et al.
Publicado: (2014)

Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization
por: Hashemi, Jamileh, et al.
Publicado: (2013)

Parafibromin as a Diagnostic Instrument for Parathyroid Carcinoma-Lone Ranger or Part of the Posse?
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

Genomics and Epigenomics in Parathyroid Neoplasia: from Bench to Surgical Pathology Practice
por: Juhlin, C. Christofer, et al.
Publicado: (2020)

The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas
por: Andreasson, Adam, et al.
Publicado: (2013)

Metastatic malignant melanoma with neuroendocrine differentiation: a case report and review of the literature
por: Juhlin, Carl Christofer, et al.
Publicado: (2020)

Parathyroid Adenoma With Respiratory-Like Epithelium: Case Report of a Potential Mimic With Unknown Etiology
por: Juhlin, C. Christofer, et al.
Publicado: (2021)

Distinguishing between thyroid and parathyroid nodules by ultrasound: a potential game-changer in clinical practice?
por: Juhlin, C. Christofer, et al.
Publicado: (2023)

Parathyroid carcinoma during pregnancy: a novel pathogenic CDC73 mutation – a case report
por: Dematapitiya, Chinthana, et al.
Publicado: (2022)

SAT187 A Case Of CDC73 Mutation Related Primary Hyperparathyroidism With Ectopic Parathyroid Hyperplasia
por: Wu, Tao, et al.
Publicado: (2023)

FRI692 Severe Hyperparathyroidism And Nephrolithiasis In An Adolescent Male Due To CDC73 Positive Parathyroid Carcinoma
por: Nguyen, Jennifer T, et al.
Publicado: (2023)

Solid Cell Nests Within a Parathyroid Gland—Report of an Exceptional Case
por: Juhlin, C. Christofer, et al.
Publicado: (2018)

Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: An in vivo and in vitro study
por: Fotouhi, Omid, et al.
Publicado: (2014)

Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features
por: Gill, Anthony J., et al.
Publicado: (2019)

Extensive Bilateral Adrenal Rest Testicular Tumors in a Patient With 3β-Hydroxysteroid Dehydrogenase Type 2 Deficiency
por: Lolis, Evangelos, et al.
Publicado: (2018)

Prolactin Receptor in Primary Hyperparathyroidism – Expression, Functionality and Clinical Correlations
por: Haglund, Felix, et al.
Publicado: (2012)

Lipoadenoma of the Parathyroid Gland: Characterization of an Institutional Series Spanning 28 Years
por: Juhlin, C. Christofer, et al.
Publicado: (2020)

TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma
por: Paulsson, Johan O., et al.
Publicado: (2018)

The EIF4EBP3 translational repressor is a marker of CDC73 tumor suppressor haploinsufficiency in a parathyroid cancer syndrome
por: Zhang, J-H, et al.
Publicado: (2012)

Merkel cell polyomavirus T-antigens regulate DICER1 mRNA stability and translation through HSC70
por: Gao, Jiwei, et al.
Publicado: (2021)

TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?
por: Solhusløkk Höse, Karolina, et al.
Publicado: (2023)

Inhibition of Parathyroid Hormone Secretion by Caffeine in Human Parathyroid Cells
por: Lu, Ming, et al.
Publicado: (2013)

Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors
por: Fotouhi, Omid, et al.
Publicado: (2016)

CDC73 gene mutations in sporadic ossifying fibroma of the jaws
por: Chen, Yan, et al.
Publicado: (2016)

Cdc73 suppresses genome instability by mediating telomere homeostasis
por: Nene, Rahul V., et al.
Publicado: (2018)

USP37 Deubiquitinates CDC73 in HPT-JT Syndrome
por: Kim, Su Yeon, et al.
Publicado: (2022)

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer
por: Lindfors, Helene, et al.
Publicado: (2023)

Minimally invasive follicular thyroid carcinomas: prognostic factors
por: Stenson, Gustav, et al.
Publicado: (2016)

Molecular Characterization of Acquired Tolerance of Tumor Cells to Picropodophyllin (PPP)
por: Hashemi, Jamileh, et al.
Publicado: (2011)

5hmC Immunohistochemistry: A Predictor of TERT Promoter Mutational Status in Follicular Thyroid Carcinoma?
por: Hysek, Martin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cgju85an75duh4j57rar91m9e2